Laplace Interventional, a US-based medical device company focusing on transcatheter valve technology, recently announced the ...

"Today marks a pivotal moment in the evolution of structural heart therapy," Capstan Medical CEO Maggie Nixon said.

Capstan Medical’s robot platform has been used for the first in-human robotic assisted transcatheter mitral valve replacement ...

Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...

Capstan Medical announced its first in-human cardiac valve replacements using its catheter-based robotic surgical platform.

Mitral valve annuloplasty devices are expected to see the highest growth in the region. Increased investments in healthcare ...

Dr Rajneesh Kapoor highlights the evolution of structural heart disease treatments, exploring the impact of transcatheter ...

Capstan CEO Maggie Nixon discusses first-in-human feedback, the all-at-once approach, regulatory strategy and the tricuspid ...

Image credit: Shutterstock / LightField Studios. Capstan Medical’s robot platform has been used for the first in-human robotic assisted transcatheter mitral valve replacement procedures, confirming ...

C Medical Technologies Inc. raised $175 million in a series D financing round led by Boston Scientific Corp. The financing will support the regulatory trials and commercialization of the Altavalve ...